Altimmune ALT
NASDAQ ALT
$1.93 -0.01 (-0.52%)
At close: Nov 11, 2026 · 4:00 PM EST

Altimmune (ALT) Preferred Stock Liabilities (2017 - 2018)

Updated

Altimmune's Preferred Stock Liabilities came in at $510,083 for Q2 2018, down 91.4% from the prior quarter.

Analysis

Altimmune (ALT) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends

At the end of FY2017, Altimmune's Preferred Stock Liabilities was $9.28 million.

  • Business Quant data shows ALT's Preferred Stock Liabilities at $5.95 million (Q1 2018), $9.28 million (Q4 2017) and $8.24 million (Q3 2017) in the three quarters before Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Altimmune 377.28 Mn -764.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 9.28 Mn
Jun 30, 2018 510,083.00
Mar 31, 2018 5.95 Mn
Dec 31, 2017 9.28 Mn
Sep 30, 2017 8.24 Mn
API Access

Altimmune Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ALT&period=max&api_key=YOUR_API_KEY